# Roadmap: Future Optimization & Enterprise Scaling

**Document ID**: RD-PROD-001  
**Target Architecture**: Scalable Multi-Node Microservices

## 1. Phase 1: Performance & Inference Efficiency
*Short-term (1-3 months)*

### 1.1 Model Quantization
- **Objective**: Reduce model size from 164MB to <50MB.
- **Action**: Convert `.keras` to **TensorFlow Lite (FP16)** or **ONNX**.
- **Impact**: 300% faster inference on CPU nodes and reduced storage costs.

### 1.2 Asynchronous Inference (Celery/Redis)
- **Objective**: Decouple request lifecycle from image processing.
- **Action**: Implement **Celery** with **Redis** as the message broker.
- **Impact**: Improved user experience; prevents UI "locking" during 5s analysis.

## 2. Phase 2: High Availability & Cloud Scaling
*Mid-term (3-6 months)*

### 2.1 External Persistence (AWS S3 & RDS)
- **Object Storage**: Migrate media uploads to **Amazon S3** for 99.999% durability.
- **Database**: Migrate SQLite to **Amazon RDS (PostgreSQL)** for transactional integrity and multi-AZ failover.

### 2.2 Horizontal Scaling (ELB/ASG)
- **Architecture**: Move from a single EC2 to an **Auto-Scaling Group (ASG)** behind an **Application Load Balancer (ALB)**.
- **Impact**: Capability to handle thousands of concurrent global users.

## 3. Phase 3: Observability & Resilience
*Long-term (6-12 months)*

### 3.1 Proactive Monitoring
- **Stack**: Integration of **Prometheus** for metrics and **Grafana** for real-time dashboards.
- **Tracing**: Implement **OpenTelemetry** to track request latency across microservices.

### 3.2 Advanced Compliance & WAF
- **Security**: Implementation of **AWS WAF** with managed rule sets to block Layer-7 attacks.
- **Privacy**: Automated data anonymization protocols for PHI (Protected Health Information) compliance.

## 4. Summary of Planned ROI
Implementing this roadmap will transition the platform from a functional prototype to a mission-critical medical AI tool capable of supporting enterprise-level traffic with global availability.
